… Tumor markers are assuming a growing role in all aspects of … , and their judicious application
in clinical practice needs a thorough … uses of tumor markers in routine clinical practice are …

… , tumor markers are potentially used in screening for early malignancy. In symptomatic patients,
markers … markers in clinical practice and summarize published guidelines for their use. …

… of Clinical Oncology (ASCO) previously published evidence-based clinical practice guidelines
on uses of tumor markers in breast 1 and GI 2 cancers. Increasing clinical research on …

… serum and tissue-based tumor markers in current clinical practice. Two other subcommittees
… use of tumor markers in routine practice include formulation of the correct clinical questions …

… most appropriate use of tumor markers, are already … tumor markers in clinical practice.
Careful audit studies are also required to establish the impact of these guidelines on the practice …

… OBJECTIVE: To update the 1997 clinical practice guidelines for the use of tumor marker …
care of patients outside of clinical trials. OPTIONS: Six tumor markers for colorectal cancer and …

… ) (Table I) and which is now being used in clinical practice, is the urokinase-type plasminogen
activation system with its components urokinase-type plasminogen activator (uPA) and …

… While these factors are widely employed in clinical practice, they are less than ideal for
predicting patient outcome. Some of the limitations of these factors are listed in Table 5. …

… clinical practice; studies reporting promising results were frequently advocated to sustain the
utilization of the marker. … to the health care sector – clinical practice guidelines (CPGs) have …

… The most commonly used tumor markers in clinical practice for breast, gastrointestinal, …
clinical use of tumor markers. Clinical practice guidelines from The ASCO (https://www.asco.org/…